Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,522 | Dovepress* | 11,259+ | 1,741 | 13,000 | |
| PubMed Central* | 1,263 | 493 | 1,756 | ||
| Totals | 12,522 | 2,234 | 14,756 | ||
|
*Since 16 March 2015 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar